Pharmaceutical Industry

Investors Reassess Large Pharmaceutical Firms Amid Technological Shifts
Pharmaceutical Industry

Investors Reassess Large Pharmaceutical Firms Amid Technological Shifts

Investors are re-evaluating large pharmaceutical companies due to innovations in GLP-1, AI-driven drug discovery, and changing healthcare consumption patterns, according to VanEck.

Trending topics